Yosuf El-Shabrawi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yosuf El-Shabrawi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anton Haas
Graz, Austria
4 shared publications - Martin Weger
Department of Ophthalmology, Medical University of Graz, Graz, Austria
4 shared publications Iris Steinbrugger
Graz, Austria
3 shared publicationsOtto Schmut
Graz, Austria
3 shared publications- Wilfried Renner
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria
3 shared publications - Andreas Wedrich
Universitäts-Augenklinik, Medizinische Universität Graz, Graz, Österreich
2 shared publications
Latest Publications
- Open Access
- 3 September 2020
- Published by Springer Nature in Spektrum der Augenheilkunde
- Vol. 34 (5-6) , 162-165
Kataraktoperationen bei Uveitis
Zusammenfassung: Die Katarakt stellt bis heute eine maßgebliche Ursache für Visusverlust bei Patienten mit einer Entzündung der Uvea dar. Mehrere Studien der letzten Jahre zeigten hier zwar, dass eine Kataraktoperation eine Verbesserung des Visus erzielen kann, die Prognose jedoch im Vergleich zu einer normalen Patientengruppe stark reduziert ist.
- 3 September 2020
- Published by Springer Nature in Spektrum der Augenheilkunde
- Vol. 34 (5-6) , 162-165
Open AccessKataraktoperationen bei Uveitis
Zusammenfassung: Die Katarakt stellt bis heute eine maßgebliche Ursache für Visusverlust bei Patienten mit einer Entzündung der Uvea dar. Mehrere Studien der letzten Jahre zeigten hier zwar, dass eine Kataraktoperation eine Verbesserung des Visus erzielen kann, die Prognose jedoch im Vergleich zu einer normalen Patientengruppe stark reduziert ist.
- Open Access
- 17 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e62244
Association between Polymorphism of the Vitamin D Metabolism Gene CYP27B1 and HLA-B27-Associated Uveitis. Is a State of Relative Immunodeficiency Pathogenic in HLA B27-Positive Uveitis?
Objective Polymorphisms of the vitamin D metabolism gene CYP27B1 showed associations with multiple autoimmune diseases. The aim of this study was to investigate a possible association between the rs703842 A>G polymorphism of the CYP27B1 gene and HLA-B27-associated uveitis. Design One hundred fifty-nine patients with HLA-B27-associated uveitis, 138 HLA-B27-negative controls and 100 HLA-B27-positive controls were recruited for this retrospective case-control study. Main outcome parameters were genotype distribution and allelic frequencies determined by polymerase chain reaction. Results Carriers of the rs703842G allele were found significantly more often in patients with HLA-B27-associated uveitis than in HLA-B27-positive controls ( p = 0.03). Between patients and HLA-B27-negative controls no significant difference in the genotype distribution of the rs703842 A>G polymorphism was found ( p = 0.97). Conclusions Our data suggest that the rs703842 A>G polymorphism may play a role in HLA-B27-associated uveitis.
- 17 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e62244
Open AccessAssociation between Polymorphism of the Vitamin D Metabolism Gene CYP27B1 and HLA-B27-Associated Uveitis. Is a State of Relative Immunodeficiency Pathogenic in HLA B27-Positive Uveitis?
Objective Polymorphisms of the vitamin D metabolism gene CYP27B1 showed associations with multiple autoimmune diseases. The aim of this study was to investigate a possible association between the rs703842 A>G polymorphism of the CYP27B1 gene and HLA-B27-associated uveitis. Design One hundred fifty-nine patients with HLA-B27-associated uveitis, 138 HLA-B27-negative controls and 100 HLA-B27-positive controls were recruited for this retrospective case-control study. Main outcome parameters were genotype distribution and allelic frequencies determined by polymerase chain reaction. Results Carriers of the rs703842G allele were found significantly more often in patients with HLA-B27-associated uveitis than in HLA-B27-positive controls ( p = 0.03). Between patients and HLA-B27-negative controls no significant difference in the genotype distribution of the rs703842 A>G polymorphism was found ( p = 0.97). Conclusions Our data suggest that the rs703842 A>G polymorphism may play a role in HLA-B27-associated uveitis.
- 30 April 2010
- Published by Elsevier in Ophthalmology
- Vol. 117 (4) , 856-856.e1
Thrombophilic Gene Variants
- 30 April 2010
- Published by Elsevier in Ophthalmology
- Vol. 117 (4) , 856-856.e1
Thrombophilic Gene Variants
- 24 July 2007
- Vol. 13, 1274-9
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
Exudative age-related macular degeneration (AMD) is one of the most common causes of severe visual loss. Both environmental and genetic factors, such as the complement factor H (CFH) 402H allele, have been associated with AMD. Recently, the HTRA1 -625A allele was identified as a novel risk marker in both a North American and a Chinese population. The present study was performed to evaluate the association of the HTRA1 -625A allele with exudative AMD in a Central European population. The present case-control study included 242 patients with exudative AMD and 157 control subjects. Genotypes of the HTRA1 -625G>A polymorphism were determined by a 5'-exonuclease assay (TaqMan). Determination of CFH Y402H genotypes was done by allele specific digestion of polymerase chain products. Carriers of the HTRA1 -625AA genotype were found significantly more often in AMD patients than among control subjects (27.7% versus 5.1%; pA genotypes (p=0.001). The OR increased to 9.8 (95% CI: 3.7-25.9) among subjects homozygous for the CFH 402HH genotype (p<0.001). Interaction terms between CFH and HTRA1 genotypes were not significantly associated with AMD. Our data suggest that both the HTRA1 -625A allele and the CFH 402H allele are independently associated with exudative AMD in a Central European population.
- 24 July 2007
- Vol. 13, 1274-9
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
Exudative age-related macular degeneration (AMD) is one of the most common causes of severe visual loss. Both environmental and genetic factors, such as the complement factor H (CFH) 402H allele, have been associated with AMD. Recently, the HTRA1 -625A allele was identified as a novel risk marker in both a North American and a Chinese population. The present study was performed to evaluate the association of the HTRA1 -625A allele with exudative AMD in a Central European population. The present case-control study included 242 patients with exudative AMD and 157 control subjects. Genotypes of the HTRA1 -625G>A polymorphism were determined by a 5'-exonuclease assay (TaqMan). Determination of CFH Y402H genotypes was done by allele specific digestion of polymerase chain products. Carriers of the HTRA1 -625AA genotype were found significantly more often in AMD patients than among control subjects (27.7% versus 5.1%; pA genotypes (p=0.001). The OR increased to 9.8 (95% CI: 3.7-25.9) among subjects homozygous for the CFH 402HH genotype (p<0.001). Interaction terms between CFH and HTRA1 genotypes were not significantly associated with AMD. Our data suggest that both the HTRA1 -625A allele and the CFH 402H allele are independently associated with exudative AMD in a Central European population.
- 2 October 2006
- Vol. 12, 1143-7
Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous.
This study was carried out to compare cytometric bead array (CBA) technology with conventional enzyme linked immunosorbent assay (ELISA) for the measurement of both vitreous and serum concentrations of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and angiogenin (ANG) in diabetic and non-diabetic patients. Measurement of vitreous and serum concentrations of IL-8, VEGF, and ANG using both ELISA and CBA was performed in 26 probands (13 diabetics and 13 non-diabetic control subjects). Vitreous and serum concentrations of IL-8, VEGF, and ANG determined by CBA showed a strong correlation with those measured by ELISA. Vitreous levels of IL-8, VEGF, and ANG were significantly higher in diabetics compared to non-diabetic control subjects. No significant correlation between vitreous and serum levels of any of the investigated parameters were found in either diabetics or control individuals. The present study is the first to utilize cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Measurements obtained by ELISA and CBA technologies were highly correlated for IL-8, VEGF, and ANG in both vitreous and serum samples. Diabetic individuals showed significant elevation of IL-8, VEGF, and ANG in the vitreous but not in serum samples compared to control subjects. The most striking advantage of the CBA technology is the fact that numerous parameters can be measured in parallel using a comparatively small sample volume. It is therefore more rapid and cost effective than ELISA technology. CBA technology is a new, accurate method to measure IL-8, VEGF, and ANG in the vitreous.
- 2 October 2006
- Vol. 12, 1143-7
Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous.
This study was carried out to compare cytometric bead array (CBA) technology with conventional enzyme linked immunosorbent assay (ELISA) for the measurement of both vitreous and serum concentrations of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and angiogenin (ANG) in diabetic and non-diabetic patients. Measurement of vitreous and serum concentrations of IL-8, VEGF, and ANG using both ELISA and CBA was performed in 26 probands (13 diabetics and 13 non-diabetic control subjects). Vitreous and serum concentrations of IL-8, VEGF, and ANG determined by CBA showed a strong correlation with those measured by ELISA. Vitreous levels of IL-8, VEGF, and ANG were significantly higher in diabetics compared to non-diabetic control subjects. No significant correlation between vitreous and serum levels of any of the investigated parameters were found in either diabetics or control individuals. The present study is the first to utilize cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Measurements obtained by ELISA and CBA technologies were highly correlated for IL-8, VEGF, and ANG in both vitreous and serum samples. Diabetic individuals showed significant elevation of IL-8, VEGF, and ANG in the vitreous but not in serum samples compared to control subjects. The most striking advantage of the CBA technology is the fact that numerous parameters can be measured in parallel using a comparatively small sample volume. It is therefore more rapid and cost effective than ELISA technology. CBA technology is a new, accurate method to measure IL-8, VEGF, and ANG in the vitreous.
- 1 August 2005
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 123 (8) , 1061
Pupil Ovalization After Phakic Intraocular Lens Implantation Is Associated With Sectorial Iris Hypoperfusion
Objective To investigate iris perfusion in patients with and without pupil ovalization after phakic intraocular lens implantation. Methods Comparative retrospective randomized case series of 6 participants, each with a regular pupil, and 6 participants with pupil ovalization after phakic intraocular lens implantation for high myopia were included in the study. Indocyanine green angiography was performed between 20 and 40 months (mean ± SD, 26 ± 6.1 months) after lens implantation. Results Iris perfusion defects were found in 5 of 6 patients with pupil ovalization. No perfusion deficits were noted in patients with round pupils. Conclusion Iris ovalization after phakic intraocular lens implantation may be associated with a lack of iris perfusion and with secondary ischemia. Patients with these lenses and pupil ovalization should be followed regularly.
- 1 August 2005
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 123 (8) , 1061
Pupil Ovalization After Phakic Intraocular Lens Implantation Is Associated With Sectorial Iris Hypoperfusion
Objective To investigate iris perfusion in patients with and without pupil ovalization after phakic intraocular lens implantation. Methods Comparative retrospective randomized case series of 6 participants, each with a regular pupil, and 6 participants with pupil ovalization after phakic intraocular lens implantation for high myopia were included in the study. Indocyanine green angiography was performed between 20 and 40 months (mean ± SD, 26 ± 6.1 months) after lens implantation. Results Iris perfusion defects were found in 5 of 6 patients with pupil ovalization. No perfusion deficits were noted in patients with round pupils. Conclusion Iris ovalization after phakic intraocular lens implantation may be associated with a lack of iris perfusion and with secondary ischemia. Patients with these lenses and pupil ovalization should be followed regularly.
- 1 February 2005
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (2) , 249-252
Role of the Interleukin-6 −174 G>C Gene Polymorphism in Retinal Artery Occlusion
Background and Purpose— Proinflammatory cytokines including interleukin-6 (IL-6) are supposed to play a pivotal role in the development of atherosclerosis. A common polymorphism in the promoter of the IL-6 gene (IL-6 −174G>C) affects plasma IL-6 concentrations and has been suggested as a risk factor for cardiovascular disease. The aim of the present case-control study was to investigate the role of this polymorphism for retinal artery occlusion (RAO). Methods— One hundred eighty-two patients with RAO and 307 control subjects were genotyped for the IL-6 −174G>C polymorphism. Genotypes were determined by fluorogenic exonuclease (TaqMan) assay. Results— The prevalence of the CC genotype was significantly lower in patients with RAO than in control subjects (10.4% versus 19.9%; P =0.006). Homozygosity for the C allele was associated with an odds ratio of 0.50 (95% CI, 0.28 to 0.89) for RAO. Conclusions— The CC genotype of the IL-6 −174G>C polymorphism may be associated with a protective effect against RAO.
- 1 February 2005
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (2) , 249-252
Role of the Interleukin-6 −174 G>C Gene Polymorphism in Retinal Artery Occlusion
Background and Purpose— Proinflammatory cytokines including interleukin-6 (IL-6) are supposed to play a pivotal role in the development of atherosclerosis. A common polymorphism in the promoter of the IL-6 gene (IL-6 −174G>C) affects plasma IL-6 concentrations and has been suggested as a risk factor for cardiovascular disease. The aim of the present case-control study was to investigate the role of this polymorphism for retinal artery occlusion (RAO). Methods— One hundred eighty-two patients with RAO and 307 control subjects were genotyped for the IL-6 −174G>C polymorphism. Genotypes were determined by fluorogenic exonuclease (TaqMan) assay. Results— The prevalence of the CC genotype was significantly lower in patients with RAO than in control subjects (10.4% versus 19.9%; P =0.006). Homozygosity for the C allele was associated with an odds ratio of 0.50 (95% CI, 0.28 to 0.89) for RAO. Conclusions— The CC genotype of the IL-6 −174G>C polymorphism may be associated with a protective effect against RAO.